Perceptive Advisors - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 52 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$11,450,000
+42.7%
2,489,216
-33.3%
0.22%
-45.8%
Q2 2017$8,022,000
-52.9%
3,731,342
-31.0%
0.40%
-58.4%
Q1 2017$17,037,000
+21.1%
5,408,7280.0%0.97%
-2.9%
Q4 2016$14,063,000
-33.2%
5,408,7280.0%1.00%
-26.4%
Q3 2016$21,040,000
+30.4%
5,408,728
-9.8%
1.36%
+21.5%
Q2 2016$16,129,000
-12.7%
5,995,7600.0%1.12%
-31.0%
Q1 2016$18,466,000
-20.0%
5,995,7600.0%1.62%
-5.2%
Q4 2015$23,084,000
-39.6%
5,995,760
-52.1%
1.71%
+11.9%
Q3 2015$38,210,000
+37.1%
12,528,120
+90.6%
1.53%
-9.1%
Q2 2015$27,874,000
+9.8%
6,574,0600.0%1.68%
-14.9%
Q1 2015$25,376,000
-42.6%
6,574,0600.0%1.97%
-46.8%
Q4 2014$44,243,000
+22.6%
6,574,0600.0%3.71%
-4.3%
Q3 2014$36,092,000
-46.4%
6,574,0600.0%3.88%
-41.4%
Q2 2014$67,384,000
-14.7%
6,574,0600.0%6.61%
-20.3%
Q1 2014$78,954,000
+6.2%
6,574,0600.0%8.30%
-7.1%
Q4 2013$74,353,000
-41.1%
6,574,060
-43.9%
8.93%
+71.7%
Q3 2013$126,308,000
+172.1%
11,716,800
+133.9%
5.20%
+11.1%
Q2 2013$46,428,0005,008,4004.68%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Kovack Advisors, Inc. 24,393$82,0000.02%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders